The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature

Objective: Our objective was to characterize the safety and efficacy of the 180 W XPS-GreenLight laser in men with lower urinary tract symptoms secondary to a small volume benign prostatic hyperplasia (BPH). Methods: A retrospective analysis was performed for all patients who underwent 180 W XPS-laser photoselective vaporization of the prostate (PVP) vaporization of the prostate between 2012 and 2016 at two-tertiary medical centers. Data collection included baseline comorbidities, disease-specific quality of life scores, maximum urinary flow rate (Q(max)), postvoid residual (PVR), complications, prostate volume and prostate-specific antigen (PSA). The secondary endpoints were the incidence of intraoperative and postoperative adverse events. Complications were stratified using the Clavien-Dindo grading system up to 90 days after surgery. Results: Mean age of men was 67.8 years old, with a mean body mass index of 29.7 kg/m(2). Mean prostate volume as measured by transrectal ultrasound was 29 mL. Anticoagulation use was 47% and urinary retention with catheter at time of surgery was 17%. Mean hospital stay and catheter time were 0.5 days. Median follow-up time was 6 months with the longest duration of follow-up being 22.5 months (interquartile range, 3-22.5 months). The International Prostate Symptom Score improved from 22.8 +/- 7.0 at baseline to 10.7 +/- 7.4 (p < 0.01) and 6.3 +/- 4.4 (p < 0.01) at 1 and 6 months, respectively. The Q(max) improved from 7.70 +/- 4.46 mL/s at baseline to 17.25 +/- 9.30 mL/s (p < 0.01) and 19.14 +/- 7.19 mL/s (p < 0.001) at 1 and 6 months, respectively, while the PVR improved from 216.0 +/- 271.0 mL preoperatively to 32.8 +/- 45.3 mL (p < 0.01) and 26.2 +/- 46.0 mL (p < 0.01) at 1 and 6 months, respectively. The PSA dropped from 1.97 +/- 1.76 ng/mL preoperatively to 0.71 +/- 0.61 ng/mL (p < 0.01) and 0.74 +/- 0.63 ng/mL at 1 and 6 months, respectively. No patient had a bladder neck contracture postoperatively and no capsular perforations were noted intraoperatively. Conclusion: The 180 W GreenLight XPS system is safe and effective for men with small volume BPH. PVP produced improvements in symptomatic and clinical parameters without any safety concern. It represents a safe surgical option in this under studied population. (C) 2019 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.